Health Condition 1: J00- Acute nasopharyngitis [common cold] Health Condition 2: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged from 1-5 years of either sex 2. Children having history of recurrent respiratory infections 3. Children with recurrent G.I.T. diseases 4. Children with a recurrent fever 5. Children with recurrent episodes of diarrhoea.
Exclusion criteria
Exclusion criteria: 1. Children suffering from major systemic illness. 2. Children diagnosed with malignancy 3. Children with altered Liver functions, Renal functions. 4. Children associated with Co-morbidity. 5. Children with Congenital anomalies and hereditary disease. 6. Children with H/O of hypersensitivity to any of the trial drug or any of its ingredients. 7. Subjects who have completed participation in any other clinical trial during the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure change in Serum IgG levels before and after treatment. Timepoint: Baseline, 14th day, 28th day, 42th day and 56th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| (a) Reduction in Morbidity rate in children.Timepoint: Baseline, 14th day, 28th day, 42th day and 56th day. | — |
Countries
India
Contacts
National Institute of Ayurveda, Jaipur